Search

Search Constraints

You searched for: Author/Creator Drobne, David

Search Results

2. A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. Issue 4 (2nd August 2019)

3. A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. Issue 4 (4th March 2020)

4. Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis. Issue 5 (18th May 2023)

5. Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms. (10th April 2021)

7. Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease. Issue 6 (1st July 2019)

8. Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease. Issue 6 (July 2019)

9. Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey. (April 2021)

10. Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy. Issue 1 (15th May 2020)